A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs ASB 17061 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Asubio Pharmaceuticals
- 03 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Nov 2013 New trial record